5 recruiting, 2 enrolling by invitation, 1 active not recruiting, 1 temporarily not available. 4 Not applicable, 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Recruiting 2, Active not recruiting 1, Enrolling by invitation 1 |
| Phase 4 | 3 | Recruiting 3 |
Follow DFU: new trials by email Literature Review of DFU trials Research Report on DFU
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BIO-SEE: Bioburden Imaging Outcome Study for Equivalence Evaluation cureVision cV - DFU, VLU | Not applicable | Enrolling by invitation | Capsicure, LLC | 100 | 2026-06-10 | 2026-06-11 |
| Case Series of StimLabs Dehydrated Human Umbilical Cord Particulate for Acute and Chronic Wounds Corplex P is used to cover, protect, and provide a moist wound environment - Chronic Ulcers, Diabetic Foot Ulcers (DFU) | Enrolling by invitation | StimLabs | 10 | 2026-02-11 | 2026-04-28 | |
| Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers Tri-Membrane Wrap™ DFU, Membrane Wrap™ DFU, Membrane Wrap-Lite™ DFU - Diabetic Foot Ulcer, Foot Ulcer Chronic | Not applicable | Recruiting | BioLab Holdings | 50 | 2026-01-02 | 2026-10-01 |
| A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers XWRAP - Diabetic Foot, Foot Ulcer | Phase 4 | Recruiting | Applied Biologics, LLC | 60 | 2025-08-26 | 2026-02-11 |
| Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers Standard of Care DFU, Tri-Membrane Wrap™ DFU, Membrane Wrap™ DFU - Diabetic Foot, DFU | Phase 4 | Recruiting | BioLab Holdings | 650 | 2025-07-15 | 2025-07-28 |
| Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy Activate™ Matrix, AmnioDefend™ FT Matrix, Palisade™ DM Matrix - Diabetic Foot Ulcer, DFU | Phase 4 | Recruiting | Sequence LifeScience, Inc. | 350 | 2025-07-11 | 2026-05-19 |
| Evaluation Skin Stiffness Gradient on Skin After LLLT LLLT intervention on skin biomechanical properties in different duration and wavelength, LLLT intervention on skin biomechanical properties in different duty cycle and applied frequency - Skin Stiffness, Skin Thickness | Not applicable | Active not recruiting | Asia University | 20 | 2025-01-10 | 2026-07-02 |
| Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care SLAM + SOC, SOC - Diabetic Foot Ulcer, Diabetic Foot | Not applicable | Recruiting | Applied Biologics, LLC | 124 | 2024-09-20 | 2024-11-20 |
| Expanded Access Program Evaluating SkinTE in the Treatment of Wagner 1 Diabetic Foot Ulcers SkinTE - DFU, Neuropathic Diabetic Ulcer - Foot | Temporarily not available | PolarityTE | 2025-10-30 |
Diabetic Foot (6) · Foot Ulcer (5) · Ulcer (4) · Leg Ulcer (2) · Varicose Ulcer (2) · Wounds and Injuries (2) · Pressure Ulcer (1) · Surgical Wound (1)
Skin Diseases (7) · Skin Ulcer (7) · Skin and Connective Tissue Diseases (7) · Cardiovascular Diseases (6) · Diabetes Complications (6) · Diabetes Mellitus (6) · Diabetic Angiopathies (6) · Diabetic Neuropathies (6) · Endocrine System Diseases (6) · Vascular Diseases (6) · Foot Diseases (5) · Leg Ulcer (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Varicose Veins (2)
Applied Biologics, LLC (2) · BioLab Holdings (2) · Asia University (1) · Capsicure, LLC (1) · PolarityTE (1) · Sequence LifeScience, Inc. (1) · StimLabs (1)
United States (7) · Taiwan (1)